Key Highlights
- Trump announced deals with nine drugmakers to cut Medicaid drug prices.
- The agreements align US drug prices with those in other wealthy countries.
- Participating companies include Bristol Myers Squibb, Gilead Sciences, and Merck.
- The initiative includes a planned TrumpRx website for direct consumer sales.
- Officials expect 'massive savings' from these pricing changes.
